Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
Recruiting
Observational Study
Cystic Fibrosis (CF)
New Diagnostics
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 16 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Chris Goss · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Sputum culture has been the best approach to detect harmful bacteria in the lungs of people with cystic fibrosis (CF). With the widespread use of new CF therapies (like Trikafta and Alyftrak), it is more difficult for people with CF to produce sputum even though they still have harmful bacteria in their lungs. The SEND-CF study is being done to see if there are other ways to detect harmful bacteri…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* ≥ 16 years of age on day of study visit
* Documentation of CF Diagnosis
* Able to expectorate sputum
* Percent predicted FEV1 ≥ 30%
Exclusion Criteria:
* History of solid organ transplantation
* History of active malignancy (or treatment for malignancy) in 12 months prior to…
Contacts